Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The effect of intravenous infusion of islet amyloid polypeptide (IAPP/amylin) and calcitonin gene-related peptide (CGRP) on blood glucose and plasma insulin in the basal and glucose-stimulated state was investigated in the anaesthetized rat. Both peptides had no effect on basal blood glucose or plasma insulin but following an intravenous bolus of glucose, CGRP-treated rats were hyperglycaemic and hyperinsulinaemic compared with control animals which were similar to IAPP-treated rats. IAPP had no effect on glucose-stimulated islet insulin secretion. These results suggest that CGRP, but not IAPP, alters glucose removal in vivo.

Original publication

DOI

10.1007/BF01117233

Type

Journal article

Journal

Biosci Rep

Publication Date

08/1990

Volume

10

Pages

339 - 345

Keywords

Amyloid, Animals, Blood Glucose, Calcitonin Gene-Related Peptide, Injections, Intravenous, Insulin, Islet Amyloid Polypeptide, Islets of Langerhans, Male, Rats, Rats, Inbred Strains